CARLO GIOVANNI TRAVERSO

Profile

First Name

: CARLO

Middle Name

: GIOVANNI

Last Name

: TRAVERSO

Related Companies

Titles

Company Name

Related People

DIRECTOR

ZAFI AVNUR, ZAFI S. AVNUR, JESSICA BALLINGER, ANDREW M. BELLINGER, DOUG DACHILLE, EDMUND HARRIGAN, EDMUND P. HARRIGAN, PATRICIA HURTER, ROBERT LANGER, ROBERT S. LANGER, HELENE MADONICK, JILLIAN MOO-YOUNG, CATHERINE REYNOLDS, AMY SCHULMAN, AMY W. SCHULMAN, ASHISH SINGH, CARLO GIOVANNI TRAVERSO

DIRECTOR

CELERO SYSTEMS, INC.

XIN HUANG, ALLAN MAY, BENJAMIN PLESS

DIRECTOR

TONY CASCIANO, SOPHIE KORNOWSKI, ROBERT LANGER, MICHAEL SINGER, CARLO TRAVERSO, JASON TROUTNER

DIRECTOR

LYNDRA THERAPEUTICS, INC.

ZAFI AVNUR, ZAFI S. AVNUR, JESSICA BALLINGER, ANDREW M. BELLINGER, DOUG DACHILLE, EDMUND HARRIGAN, EDMUND P. HARRIGAN, PATRICIA HURTER, ROBERT LANGER, ROBERT S. LANGER, HELENE MADONICK, JILLIAN MOO-YOUNG, CATHERINE REYNOLDS, AMY SCHULMAN, AMY W. SCHULMAN, ASHISH SINGH, CARLO GIOVANNI TRAVERSO

DIRECTOR

SYNTIS BIO, INC.

TEYMOUR BOUTROS-GHALI, RAHUL DHANDA, RAHUL K. DHANDA, ROBERT LANGER, MARTIN MADAUS, MICHAEL NANNIZZI, CARLO GIOVANNI TRAVERSO, CHENNY ZHANG

DIRECTOR

BILAYER THERAPEUTICS, INC.

THOMAS A. COLLET, CARLO TRAVERSO GIOVANNI, JOSHUA KORZENIK, ROBERT LANGER, HUANG YEN-CHEN, DAVID ZHU

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2023-12-15

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Debt

2023-08-03

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2023-05-23

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2022-08-03

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2022-08-03

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2021-06-08

D

OTHER HEALTH CARE

DECLINE TO DISCLOSE

Debt

2020-12-02

D

OTHER

DECLINE TO DISCLOSE

Equity

2019-06-19

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2019-01-11